Vimarsana
Biggest News Aggregation in the World

Work Disorder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Work Disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Work Disorder Today - Breaking & Trending Today

Understanding Modafinil: Your Ultimate Guide To Navigating The World Of Smart Drugs - Vimarsana News

Understanding Modafinil: Your Ultimate Guide To Navigating The World Of Smart Drugs

If you're looking to enhance your cognitive capabilities or manage sleep disorders, you may consider the option to buy modafinil.

Axsome Sets Sights on Narcolepsy, Shift Work Disorder Treatment - Vimarsana News

Axsome Sets Sights on Narcolepsy, Shift Work Disorder Treatment

Axsome prepares to read out a trial for narcolepsy drug candidate AXS-12 and initiate a trial for solriamfetol in shift work disorder.

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Vimarsana News

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Total 4Q and full year 2023 net product revenue of $71.5 million and $204.9 million, respectively, representing year-over-year growth of 193% and 309%

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Vimarsana News

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

20.02.2024 - Total 4Q and full year 2023 net product revenue of $71.5 million and $204.9 million, respectively, representing year-over-year growth of 193% and 309% Auvelity 4Q and full year 2023 net product sales of $49.0 million and $130.1 million, ...

Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Total 2Q 2023 product revenue of $46.7 million Auvelity® 2Q 2023 net product sales of $27.6 million, representing 76% quarter-over-quarter growth Sunosi® 2Q 2023 net product...